Small-cap stocks had a great run in 2016, but what should investors expect from 2017? Four veteran small-cap portfolio managers share how key developments in 2016 are shaping their 2017 outlook and portfolio positioning.
Strong Results for Small-Caps in 2017 and Beyond
Lauren Romeo sees potentially rewarding long-term opportunities for small-cap stocks with strong business fundamentals.
Propelled by the post-election “Trump bump,” small-cap stocks as a whole now appear to be discounting many of the favorable macroeconomic scenarios that could unfold in 2017. Some performance may have been pulled forward into 2016, leading to more modest returns in 2017.
Deviations from expectations or delays in implementation of the new administration’s proposed plans may heighten investor uncertainty and market volatility. In addition, not all potential actions and byproducts will be positive for business, for example, trade protection and/or a stronger dollar.
Any resulting pullbacks for small-cap stock prices, however, should create potentially rewarding long-term opportunities given that many of the market trends which have benefited our investment approach still seem to be in the early innings.
These include a shift in market leadership to small-cap value from growth (particularly non-earners), a rotation to cyclical stocks from defensives, the normalization of interest rates, and a decline in correlations and increased market breadth.
As evidenced by 2016, these conditions are conducive to small-cap performance being driven by individual companies’ business fundamentals. They should thus work to the advantage of judicious stock selection more than sector allocation or momentum.
Additionally, as the cost of debt capital rises, balance sheets will matter more and more, particularly with the leverage ratio (Debt/EBITDA) for the Russell 2000 currently near past highs.
Based on our meetings with companies since the election, management confidence, along with that of their customers, has increased, which could create a virtuous circle of accelerated U.S. economic growth.
Our bottom-up approach has led us to continue to own companies with durable, high-ROIC business models trading at attractive valuations in pro-cyclical sectors, including Industrials (companies with significant operating leverage that should produce faster absolute and relative earnings growth when revenue growth picks up) and Consumer Discretionary (favorable employment trends, wage gains, and low energy prices are supportive of increased personal consumption expenditures).
Within Financials, select asset managers and financial advisory firms have priced in a fair amount of negative expectations (though in the near term the stocks tend to rise and fall with capital market gyrations).
While the sector has been on a multi-year run, Health Care may prove a more fertile hunting ground if stocks continue to underperform—it was the only negative sector in the Russell 2000 in 2016. Increased regulatory and legislative uncertainty may create valuation dislocations in individual stocks that have been undeservedly tarred with the same brush as the sector as a whole.
As 2016 marked the reversal of what had been a multi-year relative performance run for small-cap growth, defensives, and non-earners, it seems that a run for cyclicals, earners, and value in small-cap still has a way to go. Our high-quality company focus did well in this environment and could continue to do so if this situation continues.
Patience Is Key for Investors in 2017
Jay Kaplan sees the possibility of lower corporate tax rates and increased infrastructure spending as promising developments for 2017, and is cautiously waiting for more attractive valuations.
Small-cap stocks really took off after the election, accelerating the already fast pace of returns in 2016. This upswing has occurred without any meaningful correction following the mid-February low, something that puts a fair amount of risk into small-cap share prices.
So while I’m very pleased with 2016’s results, I think it’s also important to point out that the kind of high double-digit run small-caps enjoyed is not sustainable without some retrenchment, especially given how rich valuations looked at the end of 2016, I see that as a headwind as we enter the new year.
At some point in 2017, we may see a lower corporate tax rate, repatriation, deregulation, and increased infrastructure spending from the new administration and Congress. These developments all look very promising.
Increased infrastructure spending would boost cyclical stocks, while a lower corporate tax rate would be a positive for most small-cap stocks regardless of sector. In another positive sign, the Fed’s decision to raise rates in December showed that they are bullish on our economy.
Yet there are still some important questions: How much of the positive effect of these policy changes have newly confident investors already priced in? How many of these changes will actually take effect in 2017? Will a delay in implementation tamp down investor optimism? What effect will higher interest rates have?
Along with a strengthening dollar, which would be a headwind for industrial stocks, the uncertainty behind the timing and extent of these proposals creates additional risk. There is no guarantee that we’ll see more robust GDP growth this year, though many equity investors are behaving as if we will. If GDP growth stalls in the first half of the year, that could spur a correction.
As 2016 drew to a close, I was working to high-grade my portfolios. While many of my holdings looked pretty richly priced, I’m generally hanging on to those that have a combination of high quality and strong fundamentals and selling or significantly trimming those that looked even more richly priced or have more business risk than I’m willing to tolerate at their current valuation.
Given my contrarian approach, it’s been hard to find exciting new ideas because most of the cheap stocks I’ve been investigating have turned out to be priced that way for very good reasons—they look like classic value traps. Patience is key right now. I expect interesting buying opportunities to materialize when some of the current widespread optimism dissipates. I’m prepared to wait. And if we do get a correction, I’ll act opportunistically, consistent with what I’ve always done when the market goes south.
U.S. Small-Caps Are The Sweet Spot for Asset Allocation in 2017
An absolute value investor, Charlie Dreifus is cautiously monitoring an investment climate marked by increased confidence and sees U.S. small-caps as a sweet spot for current asset allocation.
The increased confidence in the equity markets is good. It removes the excessive hesitancy that we observed in 2016. Overconfidence, however, is usually a sign of a market top.
Have investors pulled forward 2017 returns more than sufficiently? I think so. Clearly, they have already discounted better growth. Perhaps the market is priced to perfection already with no margin of safety for delays, errors, or world events.
Prior to the election, I thought that the market was attractively valued only relative to the 10-year Treasury. Since then, the market has risen (thus lowering my cap rate), as has the yield on the 10-year (thus raising the cost of capital), leaving one to conclude that the market is now even less attractive than it was before the